I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell of artery | 3 studies | 44% ± 27% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell of artery | 3 studies | 44% ± 27% |
Insufficient scRNA-seq data for expression of EGFL8 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| brain | 99% | 1143.79 | 2609 / 2642 | 76% | 1.96 | 535 / 705 |
| skin | 94% | 1445.81 | 1705 / 1809 | 58% | 1.59 | 273 / 472 |
| uterus | 100% | 2589.06 | 170 / 170 | 47% | 0.82 | 214 / 459 |
| kidney | 100% | 1448.62 | 89 / 89 | 46% | 1.20 | 417 / 901 |
| bladder | 100% | 1694.90 | 21 / 21 | 39% | 0.73 | 198 / 504 |
| adrenal gland | 99% | 1020.03 | 255 / 258 | 40% | 0.64 | 93 / 230 |
| ovary | 100% | 4335.38 | 180 / 180 | 36% | 0.75 | 156 / 430 |
| intestine | 100% | 1879.26 | 966 / 966 | 34% | 0.57 | 180 / 527 |
| breast | 100% | 1794.20 | 459 / 459 | 34% | 0.61 | 377 / 1118 |
| prostate | 100% | 2308.78 | 245 / 245 | 33% | 0.51 | 165 / 502 |
| thymus | 100% | 1554.63 | 651 / 653 | 32% | 0.57 | 195 / 605 |
| stomach | 100% | 1166.39 | 358 / 359 | 27% | 0.39 | 76 / 286 |
| esophagus | 100% | 1860.95 | 1445 / 1445 | 24% | 0.35 | 44 / 183 |
| pancreas | 78% | 415.15 | 255 / 328 | 44% | 0.71 | 78 / 178 |
| lung | 99% | 1323.63 | 571 / 578 | 23% | 0.37 | 261 / 1155 |
| spleen | 100% | 1324.33 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 1.33 | 1 / 1 |
| adipose | 100% | 1652.92 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1350.05 | 1331 / 1335 | 0% | 0 | 0 / 0 |
| liver | 84% | 503.09 | 190 / 226 | 11% | 0.20 | 46 / 406 |
| heart | 95% | 850.36 | 817 / 861 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 56% | 1.94 | 45 / 80 |
| muscle | 47% | 218.24 | 378 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 14% | 62.05 | 130 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 7% | 0.10 | 3 / 45 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0048856 | Biological process | anatomical structure development |
| GO_0001701 | Biological process | in utero embryonic development |
| GO_0009986 | Cellular component | cell surface |
| GO_0005576 | Cellular component | extracellular region |
| GO_0005509 | Molecular function | calcium ion binding |
| GO_0005102 | Molecular function | signaling receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | EGFL8 |
| Protein name | Epidermal growth factor-like protein 8 Epidermal growth factor-like protein 8 (EGF-like protein 8) (Vascular endothelial statin-2) (VE-statin-2) EGF like domain multiple 8 (Epidermal growth factor-like protein 8) |
| Synonyms | C6orf8 UNQ8752/PRO29920 NG3 |
| Description | |
| Accessions | ENST00000433364.5 ENST00000436155.5 ENST00000432129.1 ENST00000423079.1 Q5JP22 ENST00000413733.5 ENST00000447331.6 ENST00000414111.6 A0A140T9I6 ENST00000399648.5 Q99944 ENST00000418522.1 ENST00000452189.6 ENST00000333845.11 ENST00000395512.5 ENST00000450526.5 ENST00000443511.6 ENST00000454755.1 ENST00000422193.1 ENST00000421005.1 ENST00000452290.5 ENST00000455889.6 ENST00000418252.5 ENST00000411747.1 |
